Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Related structures:
AlphaFold database: E9ANT7
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 14 |
GO:0003677 | DNA binding | 4 | 14 |
GO:0005488 | binding | 1 | 14 |
GO:0097159 | organic cyclic compound binding | 2 | 14 |
GO:1901363 | heterocyclic compound binding | 2 | 14 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 45 | 49 | PF00656 | 0.458 |
CLV_NRD_NRD_1 | 151 | 153 | PF00675 | 0.636 |
CLV_NRD_NRD_1 | 172 | 174 | PF00675 | 0.667 |
CLV_NRD_NRD_1 | 188 | 190 | PF00675 | 0.677 |
CLV_NRD_NRD_1 | 43 | 45 | PF00675 | 0.407 |
CLV_PCSK_KEX2_1 | 151 | 153 | PF00082 | 0.627 |
CLV_PCSK_KEX2_1 | 172 | 174 | PF00082 | 0.677 |
CLV_PCSK_KEX2_1 | 188 | 190 | PF00082 | 0.344 |
CLV_PCSK_KEX2_1 | 43 | 45 | PF00082 | 0.404 |
CLV_PCSK_PC1ET2_1 | 172 | 174 | PF00082 | 0.680 |
CLV_PCSK_SKI1_1 | 174 | 178 | PF00082 | 0.631 |
CLV_PCSK_SKI1_1 | 206 | 210 | PF00082 | 0.489 |
CLV_PCSK_SKI1_1 | 224 | 228 | PF00082 | 0.255 |
CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.375 |
DEG_APCC_DBOX_1 | 205 | 213 | PF00400 | 0.507 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.324 |
DOC_CDC14_PxL_1 | 125 | 133 | PF14671 | 0.599 |
DOC_CYCLIN_RxL_1 | 188 | 200 | PF00134 | 0.632 |
DOC_CYCLIN_RxL_1 | 26 | 38 | PF00134 | 0.376 |
DOC_PP1_RVXF_1 | 119 | 126 | PF00149 | 0.674 |
DOC_USP7_UBL2_3 | 247 | 251 | PF12436 | 0.501 |
DOC_WW_Pin1_4 | 100 | 105 | PF00397 | 0.393 |
DOC_WW_Pin1_4 | 43 | 48 | PF00397 | 0.494 |
LIG_14-3-3_CanoR_1 | 173 | 181 | PF00244 | 0.698 |
LIG_14-3-3_CanoR_1 | 231 | 239 | PF00244 | 0.410 |
LIG_14-3-3_CanoR_1 | 87 | 95 | PF00244 | 0.384 |
LIG_14-3-3_CanoR_1 | 9 | 13 | PF00244 | 0.419 |
LIG_deltaCOP1_diTrp_1 | 17 | 21 | PF00928 | 0.403 |
LIG_FHA_1 | 118 | 124 | PF00498 | 0.688 |
LIG_FHA_1 | 175 | 181 | PF00498 | 0.634 |
LIG_LIR_Gen_1 | 48 | 58 | PF02991 | 0.501 |
LIG_LIR_Gen_1 | 73 | 84 | PF02991 | 0.382 |
LIG_LIR_Nem_3 | 122 | 128 | PF02991 | 0.657 |
LIG_LIR_Nem_3 | 17 | 21 | PF02991 | 0.382 |
LIG_LIR_Nem_3 | 269 | 273 | PF02991 | 0.485 |
LIG_LIR_Nem_3 | 48 | 54 | PF02991 | 0.473 |
LIG_LIR_Nem_3 | 73 | 79 | PF02991 | 0.405 |
LIG_PTB_Apo_2 | 99 | 106 | PF02174 | 0.393 |
LIG_SH2_GRB2like | 110 | 113 | PF00017 | 0.501 |
LIG_SH2_PTP2 | 29 | 32 | PF00017 | 0.421 |
LIG_SH2_PTP2 | 51 | 54 | PF00017 | 0.501 |
LIG_SH2_STAP1 | 268 | 272 | PF00017 | 0.593 |
LIG_SH2_STAT5 | 268 | 271 | PF00017 | 0.590 |
LIG_SH2_STAT5 | 29 | 32 | PF00017 | 0.421 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.377 |
LIG_SH3_3 | 123 | 129 | PF00018 | 0.646 |
LIG_SUMO_SIM_anti_2 | 207 | 213 | PF11976 | 0.614 |
LIG_SUMO_SIM_par_1 | 207 | 213 | PF11976 | 0.595 |
LIG_TRAF2_1 | 168 | 171 | PF00917 | 0.644 |
LIG_TRAF2_1 | 38 | 41 | PF00917 | 0.499 |
MOD_CDC14_SPxK_1 | 103 | 106 | PF00782 | 0.408 |
MOD_CDK_SPxK_1 | 100 | 106 | PF00069 | 0.408 |
MOD_CK1_1 | 124 | 130 | PF00069 | 0.641 |
MOD_CK1_1 | 65 | 71 | PF00069 | 0.393 |
MOD_CK2_1 | 215 | 221 | PF00069 | 0.480 |
MOD_CK2_1 | 35 | 41 | PF00069 | 0.499 |
MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.408 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.661 |
MOD_GSK3_1 | 96 | 103 | PF00069 | 0.366 |
MOD_LATS_1 | 229 | 235 | PF00433 | 0.426 |
MOD_N-GLC_1 | 117 | 122 | PF02516 | 0.656 |
MOD_N-GLC_1 | 19 | 24 | PF02516 | 0.499 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.393 |
MOD_NEK2_1 | 86 | 91 | PF00069 | 0.384 |
MOD_NEK2_2 | 249 | 254 | PF00069 | 0.472 |
MOD_PIKK_1 | 86 | 92 | PF00454 | 0.407 |
MOD_PKA_1 | 174 | 180 | PF00069 | 0.616 |
MOD_PKA_2 | 174 | 180 | PF00069 | 0.616 |
MOD_PKA_2 | 215 | 221 | PF00069 | 0.489 |
MOD_PKA_2 | 36 | 42 | PF00069 | 0.441 |
MOD_PKA_2 | 8 | 14 | PF00069 | 0.421 |
MOD_PKA_2 | 86 | 92 | PF00069 | 0.384 |
MOD_Plk_1 | 121 | 127 | PF00069 | 0.668 |
MOD_Plk_4 | 8 | 14 | PF00069 | 0.414 |
MOD_ProDKin_1 | 100 | 106 | PF00069 | 0.393 |
MOD_ProDKin_1 | 43 | 49 | PF00069 | 0.494 |
TRG_DiLeu_BaEn_1 | 207 | 212 | PF01217 | 0.614 |
TRG_ENDOCYTIC_2 | 29 | 32 | PF00928 | 0.421 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.438 |
TRG_ENDOCYTIC_2 | 64 | 67 | PF00928 | 0.270 |
TRG_ER_diArg_1 | 150 | 152 | PF00400 | 0.646 |
TRG_ER_diArg_1 | 173 | 176 | PF00400 | 0.673 |
TRG_ER_diArg_1 | 187 | 189 | PF00400 | 0.677 |
TRG_NES_CRM1_1 | 207 | 221 | PF08389 | 0.519 |
TRG_NLS_MonoExtC_3 | 172 | 178 | PF00514 | 0.666 |
TRG_NLS_MonoExtN_4 | 172 | 177 | PF00514 | 0.665 |
TRG_Pf-PMV_PEXEL_1 | 188 | 192 | PF00026 | 0.614 |
TRG_Pf-PMV_PEXEL_1 | 206 | 210 | PF00026 | 0.406 |
TRG_Pf-PMV_PEXEL_1 | 31 | 35 | PF00026 | 0.359 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5T3 | Leptomonas seymouri | 89% | 94% |
A0A0S4JCN1 | Bodo saltans | 26% | 85% |
A0A0S4JLV2 | Bodo saltans | 53% | 95% |
A0A1X0NMT4 | Trypanosomatidae | 68% | 94% |
A0A3R7KK47 | Trypanosoma rangeli | 67% | 94% |
A0A3S5H6K3 | Leishmania donovani | 97% | 100% |
A4H6S6 | Leishmania braziliensis | 92% | 100% |
A4HV54 | Leishmania infantum | 97% | 94% |
C9ZQD1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 65% | 94% |
D0A9C1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 68% |
Q4QGT3 | Leishmania major | 96% | 100% |
V5BHW6 | Trypanosoma cruzi | 66% | 94% |